Skip to content

Sellalax

by Laboratorio Chimico Farmaceutico A. Sella Srl Italy EUDAMED

Ref 05616Model SUPPOSTE DI GLICEROLO SELLA

EMDN G99

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-08032632600572EP Basic UDI-DIDate25 May 2023RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/MDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 24 Oct 2026

Model / Reference
SUPPOSTE DI GLICEROLO SELLA, 05616
Primary DI / UDI-DI
D-08032632600572EP
Basic UDI-DI
B-08032632600572EP
EMDN Code
G99 Gastrointestinal devices - other
Device Class
Class I
Market of Registration
Italy

Manufacturer details

EUDAMED SRN
IT-MF-000026481

Other devices from Laboratorio Chimico Farmaceutico A. Sella Srl

See all devices from Laboratorio Chimico Farmaceutico A. Sella Srl →

Properties & raw data

Show properties, registry sources and raw records
Other properties (11)
  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED 26fa089f-b742-488e-92ba-cf878c43c6a5 61 fields · synced 24 Oct 2026